503 related articles for article (PubMed ID: 35907972)
1. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
2. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Jarius S; Ringelstein M; Haas J; Serysheva II; Komorowski L; Fechner K; Wandinger KP; Albrecht P; Hefter H; Moser A; Neuen-Jacob E; Hartung HP; Wildemann B; Aktas O
J Neuroinflammation; 2016 Oct; 13(1):278. PubMed ID: 27776522
[TBL] [Abstract][Full Text] [Related]
3. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
4. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
[TBL] [Abstract][Full Text] [Related]
6. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
7. Purkinje cell (PC) antibody positivity in a patient with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
Xu L; Xian W; Li J; Yao X; Long Y
Int J Neurosci; 2022 Oct; 132(10):1043-1048. PubMed ID: 33287611
[TBL] [Abstract][Full Text] [Related]
8. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
9. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
10. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
11. KCNA2 IgG autoimmunity in neuropsychiatric diseases.
Arlt FA; Miske R; Machule ML; Broegger Christensen P; Mindorf S; Teegen B; Borowski K; Buthut M; Rößling R; Sánchez-Sendín E; van Hoof S; Cordero-Gómez C; Bünger I; Radbruch H; Kraft A; Ayzenberg I; Klausewitz J; Hansen N; Timäus C; Körtvelyessy P; Postert T; Baur-Seack K; Rost C; Brunkhorst R; Doppler K; Haigis N; Hamann G; Kunze A; Stützer A; Maschke M; Melzer N; Rosenow F; Siebenbrodt K; Stenør C; Dichgans M; Georgakis MK; Fang R; Petzold GC; Görtler M; Zerr I; Wunderlich S; Mihaljevic I; Turko P; Schmidt Ettrup M; Buchholz E; Foverskov Rasmussen H; Nasouti M; Talucci I; Maric HM; Heinemann SH; Endres M; ; Komorowski L; Prüss H
Brain Behav Immun; 2024 Mar; 117():399-411. PubMed ID: 38309639
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
13. Confabulation, amnesia and motor memory loss as a presentation of apparent ITPR1 antibody autoimmune encephalitis.
Schiff JR; Fiorillo BP; Sadjadi R; Henry TL; Gruen JK; Gensler LM
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34531236
[TBL] [Abstract][Full Text] [Related]
14. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
[No Abstract] [Full Text] [Related]
15. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
Doss S; Nümann A; Ziegler A; Siebert E; Borowski K; Stöcker W; Prüss H; Wildemann B; Endres M; Jarius S
J Neuroimmunol; 2014 Feb; 267(1-2):102-4. PubMed ID: 24439423
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
Damato V; Papi C; Spagni G; Evoli A; Silvestri G; Masi G; Sabatelli E; Campetella L; McKeon A; Andreetta F; Riso V; Monte G; Luigetti M; Primiano G; Calabresi P; Iorio R
Eur J Neurol; 2022 Feb; 29(2):564-572. PubMed ID: 34710286
[TBL] [Abstract][Full Text] [Related]
17. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
Garza M; Piquet AL
Front Neurol; 2021; 12():683048. PubMed ID: 34489848
[TBL] [Abstract][Full Text] [Related]
18. Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens.
Klein da Costa B; de Oliveira Pinto P; Staub L; Hansel G; Vanik Pinto G; Porcello Schilling L; Rodrigues Dos Passos G; Alves Martins W; Becker J; Machado Castilhos R; Palmini A; Sato DK
Mult Scler Relat Disord; 2023 Dec; 80():105022. PubMed ID: 37864878
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: A case report.
Gong S; Han Y; He E; Liu M; Fu X; Deng F
Front Immunol; 2022; 13():955170. PubMed ID: 35967304
[TBL] [Abstract][Full Text] [Related]
20. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]